UK accuses drugmakers and distributor of non-compete agreements

The UK’s competition enforcer has provisionally found that four companies agreed not to compete in the supply of an anti-nausea tablet to the country’s national health service, resulting in a 700% rise in the price.


Get unlimited access to all Global Competition Review content